AbbVie Inc.
Anti-B7-H3 antibodies and antibody drug conjugates
Last updated:
Abstract:
The invention relates to B7 homology 3 protein (B7-H3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Status:
Grant
Type:
Utility
Filling date:
7 Jun 2017
Issue date:
5 May 2020